Suppr超能文献

人p53蛋白β链326 - 333的体外结构-功能分析

In vitro structure-function analysis of the beta-strand 326-333 of human p53.

作者信息

Chène P, Mittl P, Grütter M

机构信息

Oncology Department and Core Drug Doscovery Technologies, Novartis CH-4002 Basel, Switzerland.

出版信息

J Mol Biol. 1997 Nov 7;273(4):873-81. doi: 10.1006/jmbi.1997.1360.

Abstract

The beta-strand 326-333 is a key structural element in the formation of p53 tetramers. To investigate the contribution of its amino acid residues, an alanine scan was performed. The oligomerisation and DNA-binding properties of the mutant proteins were compared with those of wild-type proteins in vitro and analysed on the basis of the crystal structure of the p53 tetramerisation domain at 1.5 A resolution. Two categories of mutant proteins were identified. Phe328Ala, Leu330Ala and Ile332Ala mutant proteins are inactive for DNA binding and oligomerisation, while the Glu326Ala, Tyr327Ala, Thr329Ala, Gln331Ala and Arg333Ala mutant proteins have properties similar to those of wild-type proteins. These results suggest that single mutations within the p53 tetramerisation domain destabilise the structure of the whole protein, inhibiting its DNA-binding activity. Furthermore, the mutation of leucine 330 to alanine within the tetramerisation domain of the Arg175His protein abolishes the dominant negative effect of this mutant. This shows that the beta-strand 326-333 is a key structural element that mediates the dominant negative effect of p53 mutants.

摘要

β链326 - 333是p53四聚体形成中的关键结构元件。为了研究其氨基酸残基的作用,进行了丙氨酸扫描。将突变蛋白的寡聚化和DNA结合特性与野生型蛋白在体外进行比较,并根据分辨率为1.5埃的p53四聚化结构域的晶体结构进行分析。鉴定出两类突变蛋白。苯丙氨酸328丙氨酸、亮氨酸330丙氨酸和异亮氨酸332丙氨酸突变蛋白对DNA结合和寡聚化无活性,而谷氨酸326丙氨酸、酪氨酸327丙氨酸、苏氨酸329丙氨酸、谷氨酰胺331丙氨酸和精氨酸333丙氨酸突变蛋白具有与野生型蛋白相似的特性。这些结果表明,p53四聚化结构域内的单个突变会破坏整个蛋白的结构,抑制其DNA结合活性。此外,在精氨酸175组氨酸蛋白的四聚化结构域内,亮氨酸330突变为丙氨酸消除了该突变体的显性负效应。这表明β链326 - 333是介导p53突变体显性负效应的关键结构元件。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验